LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 7, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-26
DOI
10.1038/s41419-019-1741-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways
- (2019) Qian Dong et al. CANCER LETTERS
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer
- (2018) Patricia Fernández-Nogueira et al. CANCER LETTERS
- Activation of FOXO3a reverses 5-Fluorouracil resistance in human breast cancer cells
- (2018) Ying Song et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1
- (2018) Ruoming Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy
- (2018) Jin-Fei Chen et al. Molecular Cancer
- CHP2 Promotes Cell Proliferation in Breast Cancer via Suppression of FOXO3a
- (2018) Xiaohui Zhao et al. MOLECULAR CANCER RESEARCH
- LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer
- (2018) Liyun Luo et al. ONCOGENE
- Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
- (2018) Linda Xiaoyan Li et al. Cell Death & Disease
- Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
- (2018) Melanie Royce et al. JAMA Oncology
- Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation
- (2018) Huaying Dong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway
- (2018) Liguo Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells
- (2018) Victoria J. Gennaro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci
- (2018) Shaowei Wang et al. Cell Death & Disease
- Long Non-coding RNA Structure and Function: Is There a Link?
- (2018) Anna Zampetaki et al. Frontiers in Physiology
- Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1
- (2018) Jinlan Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of Long Noncoding RNA 799 in the Metastasis of Cervical Cancer through Upregulation of TBL1XR1 Expression
- (2018) Ling-Min Liao et al. Molecular Therapy-Nucleic Acids
- Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) José Baselga et al. LANCET ONCOLOGY
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus
- (2015) K. Sakurai et al. MOLECULAR CANCER RESEARCH
- Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase
- (2014) X. Zheng et al. GENES & DEVELOPMENT
- The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness
- (2013) Diego Sisci et al. CELL CYCLE
- 1p36 Tumor Suppression--A Matter of Dosage?
- (2012) K.-O. Henrich et al. CANCER RESEARCH
- Lin-28 Homologue A (LIN28A) Promotes Cell Cycle Progression via Regulation of Cyclin-dependent Kinase 2 (CDK2), Cyclin D1 (CCND1), and Cell Division Cycle 25 Homolog A (CDC25A) Expression in Cancer
- (2012) Ning Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deletion or Epigenetic Silencing of AJAP1 on 1p36 in Glioblastoma
- (2012) N. Lin et al. MOLECULAR CANCER RESEARCH
- CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells
- (2011) K.-O. Henrich et al. CANCER RESEARCH
- CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression
- (2011) Z Liu et al. CELL DEATH AND DIFFERENTIATION
- FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
- (2011) C T Karadedou et al. ONCOGENE
- Deletion of the PER3 Gene on Chromosome 1p36 in Recurrent ER-Positive Breast Cancer
- (2010) Joan Climent et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers
- (2010) Hongxing Zhang et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started